Caplight Directory>Companies>Neuromedical-preview>Neuromedical


Neuromedical

Neuromedical

Private
ŁódźHealthcare & Life Scienceshttps://neuromedical.pl/

Last Round

Seed

Feb 18, 2026

Total Funding Raised

$2.58M

Company Overview

Neuromedical is a therapeutic devices company developing VGuard, a non-invasive vagus nerve stimulation system for the treatment of Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Alzheimer's researchresearch and developmentclinical researchdrug discoverybiotech R&Dneurodegenerative disease researchclinical trialsneurology researchbiomedical engineeringR&D services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuromedical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neuromedical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 18, 2026
SeedMay 22, 2025
SeedMay 17, 2020
View all Funding Rounds

Neuromedical Investors

Notable investors and investment history

InvestorRounds
Hard2beatSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    Raised $1.54M in a Seed round.

View all signals

Neuromedical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuromedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuromedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersŁódź
Employee Range-
Year Founded2016
Last FundingFeb 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.